TFEB在溶酶体贮积症中的调控作用及研究进展
The Regulatory Role and Research Progress of TFEB in Lysosomal Storage Disease
DOI: 10.12677/BP.2023.131001, PDF,   
作者: 程士雪, 赵梦丽：浙江工业大学长三角绿色制药协同创新中心，浙江 杭州
关键词: 溶酶体贮积症；转录因子EB；溶酶体； Lysosomal Storage Disorders； TFEB； Lysosome
摘要: 溶酶体贮积症是一种罕见的遗传缺陷疾病，由于编码溶酶体水解酶、膜转运蛋白或运输蛋白的基因突变，最终导致细胞功能障碍。转录因子EB (TFEB)是自噬和溶酶体生物发生的主要调节因子，可促进溶酶体合成及溶酶体功能的恢复。本文总结了TFEB的调节机制及TFEB的小分子激动剂在溶酶体贮积症的治疗作用及研究进展。
Abstract: Lysosomal storage disorder is a rare genetic defect disorder that ultimately leads to cell dysfunction due to mutations in genes encoding lysosomal hydrolases, membrane transporters, or transport proteins. The transcription factor EB (TFEB) is a major regu-lator of autophagy and lysosomal biogenesis, which promotes lysosomal synthesis and the recovery of lysosomal function. This article summarizes the regulatory mechanism of TFEB and the thera-peutic effect and research progress of small molecule agonists of TFEB in lysosomal storage disease.
文章引用：程士雪, 赵梦丽. TFEB在溶酶体贮积症中的调控作用及研究进展[J]. 生物过程, 2023, 13(1): 1-6. https://doi.org/10.12677/BP.2023.131001

参考文献

[1] Ballabio, A. (2016) The Awesome Lysosome. EMBO Molecular Medicine, 8, 73-76. [Google Scholar] [CrossRef] [PubMed]
[2] Xu, H. and Ren, D. (2015) Lysosomal Physiology. Annual Re-view of Physiology, 77, 57-80. [Google Scholar] [CrossRef] [PubMed]
[3] Ferreira, C.R. and Gahl, W.A. (2017) Lysosomal Storage Diseases. Translational Science of Rare Diseases, 2, 1-71. [Google Scholar] [CrossRef] 
[4] Settembre, C. and Ballabio, A. (2014) Lysosomal Adaptation: How the Lysosome Responds to External Cues. Cold Spring Harbor Perspectives in Biology, 6, Article ID: a016907. [Google Scholar] [CrossRef] [PubMed]
[5] Eskelinen, E.-L., Tanaka, Y. and Saftig, P. (2003) At the Acidic Edge: Emerging Functions for Lysosomal Membrane Proteins. Trends in Cell Biology, 13, 137-145. [Google Scholar] [CrossRef] 
[6] Saftig, P. and Klumperman, J. (2009) Lysosome Biogenesis and Lysosomal Membrane Proteins: Trafficking Meets Function. Nature Reviews Molecular Cell Biology, 10, 623-635. [Google Scholar] [CrossRef] [PubMed]
[7] Settembre, C., Fraldi, A., Medina, D.L. and Ballabio, A. (2013) Signals from the Lysosome: A Control Centre for Cellular Clearance and Energy Metabolism. Nature Reviews Molecular Cell Biology, 14, 283-296. [Google Scholar] [CrossRef] [PubMed]
[8] Lawrence, R.E. and Zoncu, R. (2019) The Lysosome as a Cellular Centre for Signalling, Metabolism and Quality Control. Nature Cell Biology, 21, 133-142. [Google Scholar] [CrossRef] [PubMed]
[9] Medina, D.L., et al. (2011) Transcriptional Activation of Lysoso-mal Exocytosis Promotes Cellular Clearance. Developmental Cell, 21, 421-430. [Google Scholar] [CrossRef] [PubMed]
[10] Lieberman, A.P., et al. (2012) Autophagy in Lysosomal Storage Disorders. Autophagy, 8, 719-730. [Google Scholar] [CrossRef] [PubMed]
[11] Peng, W., Minakaki, G., Nguyen, M. and Krainc, D. (2019) Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration. Neurotherapeutics, 16, 611-634. [Google Scholar] [CrossRef] [PubMed]
[12] Seranova, E., et al. (2017) Dysregulation of Autophagy as a Common Mechanism in Lysosomal Storage Diseases. Essays in Biochemistry, 61, 733-749. [Google Scholar] [CrossRef] 
[13] Breiden, B. and Sandhoff, K. (2019) Lysosomal Glycosphingolipid Storage Diseases. Annual Review of Biochemistry, 88, 461-485. [Google Scholar] [CrossRef] [PubMed]
[14] Parenti, G., Pignata, C., Vajro, P. and Salerno, M. (2013) New Strategies for the Treatment of Lysosomal Storage Diseases (Review). International Journal of Molecular Medicine, 31, 11-20. [Google Scholar] [CrossRef] [PubMed]
[15] Schulze, H. and Sandhoff, K. (2011) Lysosomal Lipid Storage Diseases. Cold Spring Harbor Perspectives in Biology, 3, Article ID: a004804. [Google Scholar] [CrossRef] [PubMed]
[16] Robak, L.A., et al. (2017) Excessive Burden of Lysosomal Stor-age Disorder Gene Variants in Parkinson’s Disease. Brain, 140, 3191-3203. [Google Scholar] [CrossRef] [PubMed]
[17] Rui, Y.-N., et al. (2015) Huntingtin Functions as a Scaffold for Selective Macroautophagy. Nature Cell Biology, 17, 262-275. [Google Scholar] [CrossRef] [PubMed]
[18] Steingrímsson, E., Copeland, N.G. and Jenkins, N.A. (2004) Melanocytes and the Microphthalmia Transcription Factor Network. Annual Review of Genetics, 38, 365-411. [Google Scholar] [CrossRef] [PubMed]
[19] Napolitano, G. and Ballabio, A. (2016) TFEB at a Glance. Journal of Cell Science, 129, 2475-2481. [Google Scholar] [CrossRef] [PubMed]
[20] Settembre, C., et al. (2011) TFEB Links Autophagy to Lysosomal Biogen-esis. Science, 332, 1429-1433. [Google Scholar] [CrossRef] [PubMed]
[21] Settembre, C., et al. (2013) TFEB Controls Cellular Lipid Metabolism through a Starvation-Induced Autoregulatory Loop. Nature Cell Biology, 15, 647-658. [Google Scholar] [CrossRef] [PubMed]
[22] Xu, Y., et al. (2021) TFEB Regulates Lysosomal Exocytosis of Tau and Its Loss of Function Exacerbates Tau Pathology and Spreading. Molecular Psychiatry, 26, 5925-5939. [Google Scholar] [CrossRef] [PubMed]
[23] Napolitano, G., et al. (2018) mTOR-Dependent Phosphorylation Controls TFEB Nuclear Export. Nature Communications, 9, Article No. 3312. [Google Scholar] [CrossRef] [PubMed]
[24] Puertollano, R., Ferguson, S.M., Brugarolas, J. and Ballabio, A. (2018) The Complex Relationship between TFEB Transcription Factor Phosphorylation and Subcellular Localization. The EMBO Journal, 37, e98804. [Google Scholar] [CrossRef] [PubMed]
[25] Nnah, I.C., et al. (2019) TFEB-Driven Endocytosis Coordinates MTORC1 Signaling and Autophagy. Autophagy, 15, 151-164. [Google Scholar] [CrossRef] [PubMed]
[26] Giatromanolaki, A., et al. (2015) Increased Expression of Transcription Factor EB (TFEB) Is Associated with Autophagy, Migratory Phenotype and Poor Prognosis in Non-Small Cell Lung Cancer. Lung Cancer, 90, 98-105. [Google Scholar] [CrossRef] [PubMed]
[27] Lim, J.-A., Sun, B., Puertollano, R. and Raben, N. (2018) Therapeutic Benefit of Autophagy Modulation in Pompe Disease. Molecular Therapy, 26, 1783-1796. [Google Scholar] [CrossRef] [PubMed]
[28] Raben, N., et al. (2010) Suppression of Autophagy Permits Suc-cessful Enzyme Replacement Therapy in a Lysosomal Storage Disorder—Murine Pompe Disease. Autophagy, 6, 1078-1089. [Google Scholar] [CrossRef] [PubMed]
[29] van der Ploeg, A.T. and Reuser, A.J. (2008) Pompe’s Disease. Lancet, 372, 1342-1353. [Google Scholar] [CrossRef] 
[30] Kishnani, P.S., et al. (2006) Pompe Disease Diagnosis and Management Guideline. Genetics in Medicine, 8, 267-288. [Google Scholar] [CrossRef] [PubMed]
[31] Spampanato, C., et al. (2013) Transcription Factor EB (TFEB) Is a New Therapeutic Target for Pompe Disease. EMBO Molecular Medicine, 5, 691-706. [Google Scholar] [CrossRef] [PubMed]
[32] Feeney, E.J., et al. (2013) What Else Is in Store for Autophagy? Exocytosis of Autolysosomes as a Mechanism of TFEB-Mediated Cellular Clearance in Pompe Disease. Autophagy, 9, 1117-1118. [Google Scholar] [CrossRef] [PubMed]
[33] Wheeler, S. and Sillence, D.J. (2020) Niemann-Pick Type C Disease: Cel-lular Pathology and Pharmacotherapy. Journal of Neurochemistry, 153, 674-692. [Google Scholar] [CrossRef] [PubMed]
[34] Pfeffer, S.R. (2019) NPC Intracellular Cholesterol Transporter 1 (NPC1)-Mediated Cholesterol Export from Lysosomes. Journal of Biological Chemistry, 294, 1706-1709. [Google Scholar] [CrossRef] 
[35] Pallottini, V. and Pfrieger, F.W. (2020) Understanding and Treat-ing Niemann-Pick Type C Disease: Models Matter. International Journal of Molecular Sciences, 21, Article No. 8979. [Google Scholar] [CrossRef] [PubMed]
[36] Arguello, G., et al. (2021) Genistein Activates Transcription Factor EB and Corrects Niemann-Pick C Phenotype. International Journal of Molecular Sciences, 22, Article No. 4220. [Google Scholar] [CrossRef] [PubMed]